J., Zhang, D., Zhang, X.-M., Boyer, J
Finally, arGLP-1 has been shown to improve the pre- and postprandial lipid profile, with a reduction in the levels of free fatty acids, triglycerides and LDL cholesterol, as well as the fraction of small and dense LDL and a reduction of the increase levels of triglycerides and apo-B48 postprandial.7882 Likewise, it has been reported a reduction in markers of inflammation, plasminogen activator inhibitor type 1 and leptin whereas adiponectin levels increase.47,48 Regarding the adverse effects of this family, the most important are gastrointestinal, especially nausea and vomiting of mild-moderate intensity, which are reduced with time
Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland
Is 5% weight loss a satisfactory criterion to define clinically significant weight loss
Humana Medicare : Inclusion varies